Fundraising Fox
Oyster Point Pharma, Inc.
San Francisco, US · Founded 2015 · Delaware corporation · 18,018 employees on LinkedIn · 6 known investors
Find your way into Oyster Point Pharma, Inc.
Sign up to see every warm intro you have to Oyster Point Pharma, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oyster Point Pharma, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments. Its offerings reference products such as a once-weekly combined hormonal contraceptive patch.
Founders & leadership
Oyster Point Pharma, Inc. was founded in 2015 by Jeffrey Nau.
Board
Investors · 6
How we know: Flying L Partners's portfolio page · funding news · marketscreener.com · Not right? Tell us
How we know: board seat on SEC Form D · funding news · marketscreener.com · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · marketscreener.com · Not right? Tell us
How we know: funding news · marketscreener.com · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$113.6M disclosed across 2 rounds · 2017–2019
▶$85MraisedFeb 2019 · 7 investors · PharmaceuticalsRule 506(b)
- William J LinkDirector
- D. Michael AckermannDirector
- Clare OzawaDirector
- Benjamin TsaiDirector
- Ali BehbahaniDirector
- Jeffrey NauExecutive Officer, Director
- Mark A. MurrayExecutive Officer, Director
- Offering amount
- $93M
- Amount sold
- $85M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$28.6MraisedOct 2017 · 8 investors · PharmaceuticalsRule 506(b)
- D. Michael AckermannDirector
- Mark A. MurrayExecutive Officer, Director
- William J LinkDirector
- Jeffrey NauExecutive Officer, Director
- Ali BehbahaniDirector
- Offering amount
- $43.1M
- Amount sold
- $28.6M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Oyster Point Pharma, Inc. do?
- A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments. Its offerings reference products such as a once-weekly combined hormonal contraceptive patch.
- Who founded Oyster Point Pharma, Inc.?
- Oyster Point Pharma, Inc. was founded by Jeffrey Nau in 2015.
- Who are Oyster Point Pharma, Inc.'s investors?
- Oyster Point Pharma, Inc.'s investors include Flying L Partners, New Enterprise Associates (NEA), Versant Venture AIV Holdings, Versant Ventures, Vida Ventures.
- How much funding has Oyster Point Pharma, Inc. raised?
- Oyster Point Pharma, Inc. has disclosed $113.6M raised across 2 rounds.
- Where is Oyster Point Pharma, Inc. headquartered?
- Oyster Point Pharma, Inc. is headquartered in San Francisco, US.